Andrew K. Balo - 25 Mar 2025 Form 4 Insider Report for Glucotrack, Inc. (GCTK)

Role
Director
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Issuer symbol
GCTK
Transactions as of
25 Mar 2025
Net transactions value
$0
Form type
4
Filing time
07 Oct 2025, 21:38:38 UTC
Previous filing
28 Mar 2025
Next filing
28 Mar 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Andrew K. Balo filed Form 4 for Glucotrack, Inc. (GCTK) on 07 Oct 2025."

Quick Takeaways

  • This page summarizes Andrew K. Balo's Form 4 filing for Glucotrack, Inc. (GCTK).
  • 4 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 07 Oct 2025, 21:38.

What Changed

  • Previous filing in this sequence was filed on 28 Mar 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Balo Andrew K Director C/O GLUCOTRACK, INC., 301 RTE. 17 NORTH, SUITE 800, RUTHERFORD /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact 07 Oct 2025 0001323190

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GCTK Common Stock, par value $0.001 per share Award $0 +75 $0.000000 75 25 Mar 2025 Direct
transaction GCTK Common Stock, par value $0.001 per share Award $0 +3,332 +4443% $0.000000 3,407 11 Jul 2025 Direct
transaction GCTK Common Stock, par value $0.001 per share Award $0 +1,285 +38% $0.000000 4,692 03 Oct 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GCTK Stock option (right to buy) Award $0 +4,055 $0.000000 4,055 03 Oct 2025 Common Stock, par value $0.001 per share 4,055 $7.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each option grant has a vesting commencement date of July 1 of the applicable calendar year and vests in 12 equal monthly installments over the 12-month period ending June 30 of the following year, subject to the reporting person's continued service to the Issuer through each vesting date.

Remarks:

On May 17, 2024, a 1-for-5 reverse stock split of the Issuer's common stock, par value $0.001 per share (the "Common Stock") was implemented (the "2024 Reverse Split"). On February 25, 2025, a 1-for-20 reverse stock split of the Common Stock was implemented (the "February 2025 Reverse Split"), and on June 13, 2025, a 1-for-60 reverse stock split of the Common Stock was implemented (the "June 2025 Reverse Stock Split", and together with the 2024 Reverse Split and the February 2025 Reverse Stock Split, the "Reverse Stock Splits"). All figures presented in this Form 4 reflect the Reverse Stock Splits.

Sponsored